Cutaneous and soft skin infections due to non-tuberculous mycobacteria;Infecciones cutáneas y de partes blandas por micobacterias no tuberculosas

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 28, Issue SUPPL. 1, 2010, Pages 46-50

  Alcaide, Fernando ^a,b,d   Esteban, Jaime ^c,d  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^d Grupo de Estudio de las Infecciones por Micobacterias (GEIM) de la Soc Espanola de Enfermedades Inf   (Spain)

Author keywords

Buruli ulcer; Cutaneous mycobacteriosis; M. marinum; M. ulcerans; Rapidly growing mycobacteria

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; CLARITHROMYCIN; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFABUTIN; RIFAMPICIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BURULI ULCER; CHRONIC DISEASE; CONGENITAL HYPOTHYROIDISM; GEOGRAPHIC DISTRIBUTION; HUMAN; LEPROSY; MYCOBACTERIOSIS; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM CHELONEI; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM INTRACELLULARE AVIUM; MYCOBACTERIUM KANSASII; MYCOBACTERIUM MARINUM; MYCOBACTERIUM ULCERANS; MYCOBACTERIUM XENOPEI; SKIN INFECTION; TUBERCULOSIS;

AFRICA, CENTRAL; AFRICA, WESTERN; ANTI-BACTERIAL AGENTS; AUSTRALIA; BURULI ULCER; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; IMMUNOCOMPROMISED HOST; MYCOBACTERIA, ATYPICAL; MYCOBACTERIUM INFECTIONS, ATYPICAL; MYCOBACTERIUM MARINUM; MYCOBACTERIUM ULCERANS; OPPORTUNISTIC INFECTIONS; SKIN DISEASES, BACTERIAL; SOFT TISSUE INFECTIONS; SOIL MICROBIOLOGY; WATER MICROBIOLOGY; WOUND INFECTION;

EID: 76749123848     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/S0213-005X(10)70008-2     Document Type: Article

References (44)

1. Falkinham III J.O. Epidemiology of infection by nontuberculous mycobacteria. Clin Microbiol Rev 9 (1996) 177-215
2. Alcaide F, Esteban J, González J, Palacios JJ. Micobacterias. En: Cercenado E, Cantón R, eds. Procedimientos en Microbiología Clínica. Recomendaciones de la Sociedad de Enfermedades Infecciosas y Microbiología Clínica [9a]. SEIMC; 2005 [consultado en: 2 de noviembre de 2009]. Disponible en: http://www.seimc.org/documentos/protocolos/microbiologia/cap9a.pdf.
3. Griffith D.E., Aksamit T., Brown-Elliot B.A., Catanzaro A., Daley C.L., Gordin F., et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175 (2007) 367-416
4. Alcaide F., and González J. Infecciones causadas por micobacterias ambientales. In: Rozman C., and Cardellach F. (Eds). Tratado de medicina interna Farreras-Rozman 16 (2008), Elsevier, Barcelona 2350-2354
5. Piersimoni C., and Scarparo C. Extrapulmonary infections associated with nontuberculous mycobacteria in immunocompetent persons. Emerg Infect Dis 15 (2009) 1351-1358
6. Martín-Casabona N., Bahrmand A.R., Bennedsen J., Østergaard Thomsen V., Curcio M., Fauville-Dufaux M., et al. Non-tuberculous mycobacteria: patterns of isolation. A multi-country retrospective survey. Int J Tuberc Lung Dis 8 (2004) 1186-1193
7. Escalonilla P., Esteban J., Soriano M.L., Fariña M.C., Pique E., Grilli R., et al. Cutaneous manifestations of infection by nontuberculous mycobacteria. Clin Exp Dermatol 23 (1998) 214-221
8. Bartralot R., García-Patos V., Sitjas D., Rodríguez-Cano L., Mollet J., Martín-Casabona N., et al. Clinical patterns of cutaneous nontuberculous mycobacterial infections. Br J Dermatol 152 (2005) 727-734
9. a ed. (2007), ASM Press, Washington, DC 543-572
10. a ed. (2007), ASM Press, Washington, DC 573-588
11. a ed. (2007), ASM Press, Washington, DC 589-600
12. Alcaide F. Nuevos métodos de identificación de micobacterias. Enferm Infecc Microbiol Clin 24 Supl 1 (2006) S53-S57
13. Brown-Elliott B.A., and Wallace Jr. R.J. Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev 15 (2002) 716-746
14. de Groote M.A., and Huitt G. Infections due to rapidly growing mycobacteria. Clin Infect Dis 42 (2006) 1756-1763
15. Esteban J., Martín-de-Hijas N.Z., Fernández A.I., Fernández-Roblas R., and Gadea I. Epidemiology of infections due to nonpigmented rapidly growing mycobacteria diagnosed in an urban area. Eur J Clin Microbiol Infect Dis 27 (2008) 951-957
16. van Ingen J., Boeree M.J., Dekhuijzen P.N., and van Soolingen D. Environmental sources of rapid growing nontuberculous mycobacteria causing disease in humans. Clin Microbiol Infect 15 (2009) 888-893
17. Safranek T.J., Jarvis W.R., Carson L.A., Cusick L.B., Bland L.A., Swenson J.M., et al. Mycobacterium chelonae wound infections after plastic surgery employing contaminated gentian violet skin-marking solution. N Engl J Med 317 (1987) 197-201
18. Chang S.L., Chung W.H., Huang Y.H., and Hong H.S. Bilateral sporotrichoid lymphocutaneous dermatosis in a drug abuser: case report and review of the literature. Am J Clin Dermatol 9 (2008) 393-395
19. Winthrop K.L., Abrams M., Yakrus M., Schwartz I., Ely J., Gillies D., et al. An outbreak of mycobacterial furunculosis associated with footbaths at a nail salon. N Engl J Med 346 (2002) 1366-1371
20. Vugia D.J., Jang Y., Zizek C., Ely J., Winthrop K.L., and Desmond E. Mycobacteria in nail salon whirlpool footbaths, California. Emerg Infect Dis 11 (2005) 616-618
21. Esteban J., Fernández Roblas R., García Cía J.I., Zamora N., and Ortiz A. Clinical significance and epidemiology of non-pigmented rapidly growing mycobacteria in a university hospital. J Infect 54 (2007) 135-145
22. Rivera-Olivero I.A., Guevara A., Escalona A., Oliver M., Pérez-Alfonzo R., Piquero J., et al. Infecciones en tejidos blandos por micobacterias no tuberculosas secundarias a mesoterapia. ¿Cuánto vale la belleza?. Enferm Infecc Microbiol Clin 24 (2006) 302-306
23. CDC. Rapidly growing mycobacterial infection following liposuction and liposculpture- Caracas, Venezuela, 1996-1998. Morb Mortal Weekly Rep 47 (1998) 1065-1067
24. Yuan J., Liu Y., Yang Z., Cai Y., Deng Z., Qin P., et al. Mycobacterium abscessus post-injection abscesses from extrinsic contamination of multiple-dose bottles of normal saline in a rural clinic. Int J Infect Dis 13 (2009) 537-542
25. Zhibang Y., BiXia Z., Qishan L., Lihao C., Xiangquan L., and Huaping L. Large-scale outbreak of infection with Mycobacterium chelonae subsp. abscessus after penicillin injection. J Clin Microbiol 40 (2002) 2626-2628
26. Esteban J., Cabria F., Rollán E., Fernández-Roblas R., Gadea I., and Soriano F. Characterization of rapidly growing mycobacteria using a commercial identification system. Eur J Clin Microbiol Infect Dis 19 (2000) 73-75
27. National Committee for Clinical Laboratory Standards. Susceptibility testing for mycobacteria, nocardiae, and other aerobic actinomycetes; approved standard. NCCLS document M24-A. Wayne, Pe: National Committee for Clinical Laboratory Standards; 2003.
28. Woods G.L., Bergmann J.S., Witebsky F.G., Fahle G.A., Boulet B., Plaunt M., et al. Multisite reproducibility of Etest for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum. J Clin Microbiol 38 (2000) 656-661
29. Esteban J., Gadea I., Torres M.V., Cabria F., Rollan E., Santos-O'Connor F.G., et al. A comparison between disk diffusion and microdilution for susceptibility testing of Mycobacterium fortuitum complex. J Chemother 14 (2002) 547-553
30. Martín-de-Hijas N.Z., García-Almeida D., Ayala G., Fernández-Roblas R., Gadea I., Celdrán A., et al. Biofilm development by clinical strains of non-pigmented rapidly growing mycobacteria. Clin Microbiol Infect 15 (2009) 931-936
31. Portaels F., Silva M.T., and Meyers W.M. Buruli ulcer. Clin Dermatol 27 (2009) 291-305
32. Portaels F, Meyers WM, Ablordey A, Castro AG, Chemlal K, de Rijk P, et al. First cultivation and characterization of Mycobacterium ulcerans from the Environment. PLoS Negl Trop Dis [revista electrónica]. 2008 [consultado en: 6 de noviembre de 2009];2(3):e178 [12 screens]. Disponible en: http://www.plosntds.org/article/info%3Adoi%2F10.1371%2Fjournal.pntd.0000178.
33. Asiedu K, Scherpbier R, Raviglione M. Buruli ulcer. Mycobacterium ulcerans infection. WHO/CDS/CPE/GBUI/2000.1. Ginebra: World Health Organization. 2000 [consultado en: 6 de noviembre de 2009]. Disponible en: http://whqlibdoc.who.int/hq/2000/WHO_CDS_CPE_GBUI_2000.1.pdf.
34. Ezzedine K., Pistone T., Cottin J., Marsollier L., Guir V., and Malvy D. Buruli ulcer in longterm traveler to Senegal. Emerg Infect Dis 15 (2009) 118-119
35. Herbinger K.H., Adjei O., Awua-Boateng N.Y., Nienhuis W.A., Kunaa L., Siegmund V., et al. Comparative study of the sensitivity of different diagnostic methods for the laboratory diagnosis of Buruli ulcer disease. Clin Infect Dis 48 (2009) 1055-1064
36. Radford A.J. The surgical management of lesions of ulcerans infections due to Mycobacterium ulcerans, revisited. Trans R Soc Trop Med Hyg 103 (2009) 981-984
37. World Health Organization Provisional guidance on the role of specific antibiotics in the management of Mycobacterium ulcerans disease (Buruli ulcer). 2004 [consultado en: 6 de noviembre de 2009]. Disponible en: http://www.who.int/buruli/information/antibiotics/en/index.html.
38. Johnson P.D., Hayman J.A., Quek T.Y., Fyfe J.A., Jenkin G.A., Buntine J.A., et al. Consensus recommendations for the diagnosis, treatment and control of Mycobacterium ulcerans infection (Bairnsdale or Buruli ulcer) in Victoria, Australia. Med J Aust 186 (2007) 64-68
39. Casal M., Casal M.M., and Spanish Group of Mycobacteriology. Multicenter study of incidence of Mycobacterium marinum in humans in Spain. Int J Tuberc Lung Dis 5 (2001) 197-199
40. Aubry A., Chosidow O., Caumes E., Robert J., and Cambau E. Sixty-three cases of Mycobacterium marinum infection: clinical features, treatment, and antibiotic susceptibility of causative isolates. Arch Intern Med 162 (2002) 1746-1752
41. Bråbäck M., Riesbeck K., and Forsgren A. Susceptibility of Mycobacterium marinum to gatifloxacin, gemifloxacin, levofloxacin, linezolid, moxifloxacin, telithromycin, and quinupristin-dalfopristin (synercid) compared to its susceptibilities to reference macrolides and quinolones. Antimicrob Agents Chemother 46 (2002) 1114-1116
42. Liao C.H., Lai C.C., Ding L.W., Hou S.M., Chiu H.C., Chang S.C., et al. Skin and soft tissue infection caused by non-tuberculous mycobacteria. Int J Tuberc Lung Dis 11 (2007) 96-102
43. Breathnach A., Levell N., Munro C., Natarajan S., and Pedler S. Cutaneous Mycobacterium kansasii infection: case report and review. Clin Infect Dis 20 (1995) 812-817
44. Tortoli E. Clinical features of infections caused by new nontuberculous mycobacteria, part I. Clin Microbiol Newsletter 26 (2004) 89-95